0.000USD0.000After-hours (ET)
38.97MMarket Cap
LossP/E TTM
Synchronoss Technologies Inc
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Synchronoss Technologies Inc
Currency: USD Updated: 2026-02-12 Key Insights
Synchronoss Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 153 out of 481 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 9.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Synchronoss Technologies Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Synchronoss Technologies Inc Highlights
StrengthsRisks
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-12 Its latest quarterly revenue reached 42.00M, representing a year-over-year decrease of 2.24%, while its net profit experienced a year-over-year decrease of 201.96%.
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow

Relevant data have not been disclosed by the company yet.
Key Metrics
Total revenue
Operating profit
Total assets
SG&A

Relevant data have not been disclosed by the company yet.
Key Metrics
Cash flow from operating activities
Income after tax

Relevant data have not been disclosed by the company yet.
Key Metrics
Cash flow from operating activities
Total revenue

Relevant data have not been disclosed by the company yet.
Key Metrics

Relevant data have not been disclosed by the company yet.
Synchronoss Technologies Inc's Company Valuation
Currency: USD Updated: 2026-02-12The current valuation score of Synchronoss Technologies Inc is 7.04, ranking 328 out of 481 in the Software & IT Services industry. Its current P/E ratio is -9.87, which is -376.04% below the recent high of 27.24 and -660.72% above the recent low of -75.07.
Valuation Dimensions
Industry Ranking 153/481

Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-12The current earnings forecast score of Synchronoss Technologies Inc is 6.00, ranking 383 out of 481 in the Software & IT Services industry. The average price target is 9.00, with a high of 40.00 and a low of 9.00.
Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data
Financial Forecasting

Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-12The current price momentum score of Synchronoss Technologies Inc is 8.06, ranking 29 out of 481 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 9.14 and the support level at 8.73, making it suitable for range-bound swing trading.
Support & Resistance

Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Institutional Confidence
Currency: USD Updated: 2026-02-12The latest institutional shareholding proportion is 43.57%, representing a quarter-over-quarter decrease of 3.55%. The largest institutional shareholder is The Vanguard, holding a total of 502.33K shares, representing 4.37% of shares outstanding, with 17.38% increase in holdings.
Institutional Shareholding

Relevant data have not been disclosed by the company yet.
Shareholder Activity
BlackRock Institutional Trust Company, N.A.
Allspring Global Investments, LLC
Acadian Asset Management LLC
Geode Capital Management, L.L.C.
Risk Assessment
Currency: USD Updated: 2026-02-12Synchronoss Technologies Inc’s latest ESG disclosure leads the Software & IT Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Beta vs S&P 500 index
1.42
240-Day Maximum Drawdown
+67.57%
240-Day Volatility
+92.62%
Volatility
Downside Risk-Adjusted Return
Maximum Daily Upside Volatility
Maximum Daily Downside Volatility

Synchronoss Technologies Inc
SNCR
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment

Akamai Technologies Inc
AKAM
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more